Clinical trial Recruiting at 1 site Interventional Ages 21 to 80

Improving medication adherence in patients with uncontrolled hypertension using urine tests

Official title: Utility of Urine Mass Spectrometry Analysis in Addressing Medication Non-adherence in Patients With Poorly Controlled Hypertension

Run by Changi General Hospital · NCT06938633 · Data updated 2026-11-12

This study is testing if using urine tests can help people with uncontrolled high blood pressure stick to their medication better and improve their health.

Quick facts

Study typeInterventional
Ages21 Years to 80 Years
SexAll
Enrollment100 (estimated)
SponsorChangi General Hospital
Academic / other
Locations1 site (Singapore)
StatusRecruiting
StartedFebruary 7, 2024
Main results expectedSeptember 30, 2025
Study endsSeptember 30, 2025
Registry record updatedApril 22, 2025
Trial IDNCT06938633 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 21 to 80 who have poorly controlled hypertension and are currently taking two or more antihypertensive medications.

Probably not a fit

Patients with significant kidney impairment or chronic liver disease may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to address the issue of medication non-adherence in patients with poorly controlled hypertension by utilizing urine mass spectrometry to assess adherence to antihypertensive medications. The approach involves a three-step process: first, a retrospective analysis of medication adherence in patients recently admitted for stroke; second, a prospective recruitment of participants with uncontrolled hypertension; and third, counseling for those identified as non-adherent, followed by reassessment of their medication adherence and blood pressure levels. This method is convenient, non-invasive, and cost-effective, making it suitable for clinical settings.

Why it matters

Potential benefit: If successful, this study could lead to improved blood pressure control and reduced healthcare costs for patients with hypertension.

How similar studies have gone: Other studies have shown promise in using urine tests for medication adherence, indicating that this approach is both relevant and potentially effective.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age of 21 - 80 years
2. Systolic blood pressure of ≥140 mmHg or average systolic blood pressure ≥135 mmHg, or diastolic blood pressure ≥90 mmHg or average diastolic blood pressure ≥85 mmHg, on at least two measurements
3. Currently taking 2 or more hypertension medications
4. Able to provide informed consent.

Exclusion Criteria:

* Significant kidney impairment with eGFR of less than 45mL/min/1.73m2 or on dialysis
* Known history of chronic liver disease

Where it's running

  • Changi General Hospital
    Singapore, Singapore
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.